EHA Unplugged

Improving MPNs management: EHA2026 Lifetime Achievement Award

In this episode, EHA 2026 Lifetime Achievement Award recipient Prof Claire Harrison reflects on a career dedicated to advancing the understanding and management of myelop

CAR T Toxicities in Focus: What We Have Learned from Registry Data

In this episode, Dr Annalisa Ruggeri discusses how registry data are helping clinicians better understand, monitor and manage CAR T-related toxicities. She explains how i

Life After YERM: How the Young EHA Research Meeting Shaped Careers

In the final episode of our mini-series celebrating the 10th anniversary of the Young EHA Research Meeting (YERM), we explore how the meeting acts as a powerful launching

Discover YERM: The Young EHA Research Meeting and Your Place in It

Welcome to our mini-series celebrating the 10th anniversary of the Young EHA Research Meeting (YERM) with an introduction to its history and mission. We sit down with co-

CAR-T for Pediatric B-ALL: Expert Tips

In this episode, Prof André Baruchel discusses the role of CAR T-cell therapy in children with B-cell acute lymphoblastic leukemia (B-ALL). He reviews current indications

Getting Patients to CAR T: Referral Systems in Europe

In this episode of EHA Unplugged, Prof Marion Subklewe discusses one major challenge facing CAR T-cell therapy in Europe: ensuring that eligible patients are referred for

Outpatient CAR T in Europe: Lessons from Barcelona

In this episode, Dr Alexandra Martínez Roca and Dr Beatriz Merchán Muñoz discuss how their team at Hospital Clínic de Barcelona has developed a fully outpatient programme

Smarter CARs: Using AI to Improve Chimeric Antigen Receptor Design

Artificial intelligence is opening new possibilities in the design of next-generation immunotherapies. In this episode of EHA Unplugged, Dr Andrea Schmidts discusses how

What is Real-World Evidence Revealing About CAR T Therapy?

In this episode, Prof Benoit Tessoulin examines how real-world evidence from the French DESCAR-T registry is expanding our understanding of CAR T-cell therapy beyond clin

Hematology Portraits: Prof Frank Leebeek

In this episode Prof. Frank Leebeek reflects on his career in hematology, highlighting a lifelong commitment to bridging clinical practice and research.  From his early

How to Start a Clinical Trial?

What does it take to design and lead a clinical trial in hematology? In this episode of EHA Unplugged, Prof. Elias K. Mai shares his experience transitioning from clinica

How Experts Treat Multiple Myeloma

In this episode, Prof. Pieter Sonneveld is joined by Prof. Meletios Dimopoulos and Prof. Evangelos Terpos to discuss the updated EHA–EMN (European Myeloma Network) guidel

Where Are We Now With Immunotherapy in Multiple Myeloma?

Explore the latest advancements in immunotherapies for multiple myeloma, including CAR T-cell therapy, bispecific antibodies, and antibody-drug conjugates.  In this epis

Menin Inhibitors to Treat Acute Myeloid Leukemia (AML)

Get up to date on menin inhibitors, an emerging class of targeted therapies for acute myeloid leukemia (AML). Menin is a key component of the KMT2A (lysine methyltransfer

How Experts Treat HIV-associated Lymphomas

Get up to date with the EHA–ESMO guidelines on Human immunodeficiency virus (HIV)-associated Lymphomas.  In this episode, Prof. Kai Hubel, a key author of the guidelines

Hematology Portraits: Associate Prof Meritxell Alberich Jordà

Join Meritxell Alberich Jordà, an EHA Board member and a principal investigator from Prague, as she shares her journey to becoming a recognised research scientist in hema

How Experts Treat Large B-cell Lymphoma (LBCL)

Get up to date with the latest EHA Clinical Practice Guidelines for Large B-cell lymphoma (LBCL) (⁠Large B‐cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diag

Connecting Hematology Research and Real Life: Peter Kapitein

In this episode of EHA Unplugged, patient advocate Peter Kapitein discusses the importance of connecting patients, researchers, and clinicians to accelerate cancer resear

How Experts Treat Peripheral T- and NK-cell Lymphomas

Get up to date with the latest ESMO-EHA guideline for Peripheral T- and natural killer-cell lymphomas (Peripheral T‐ and natural killer‐cell lymphomas: ESMO‐EHA Clinical

Hematology Portraits: Prof Konstanze Döhner

Join EHA President  Prof  Konstanze Döhner  from  University Hospital Ulm in Germany as she discusses her deep interest in hematology, both in research and in the clinics